129 related articles for article (PubMed ID: 16293185)
1. Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: study in paraffin tissue sections.
Dambaki C; Kogia C; Kampa M; Darivianaki K; Nomikos M; Anezinis P; Theodoropoulos PA; Castanas E; Stathopoulos EN
BMC Cancer; 2005 Nov; 5():148. PubMed ID: 16293185
[TBL] [Abstract][Full Text] [Related]
2. The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line.
Kampa M; Papakonstanti EA; Alexaki VI; Hatzoglou A; Stournaras C; Castanas E
Exp Cell Res; 2004 Apr; 294(2):434-45. PubMed ID: 15023532
[TBL] [Abstract][Full Text] [Related]
3. The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton.
Kampa M; Papakonstanti EA; Hatzoglou A; Stathopoulos EN; Stournaras C; Castanas E
FASEB J; 2002 Sep; 16(11):1429-31. PubMed ID: 12205037
[TBL] [Abstract][Full Text] [Related]
4. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors.
Papakonstanti EA; Kampa M; Castanas E; Stournaras C
Mol Endocrinol; 2003 May; 17(5):870-81. PubMed ID: 12554777
[TBL] [Abstract][Full Text] [Related]
5. Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells.
Kampa M; Kogia C; Theodoropoulos PA; Anezinis P; Charalampopoulos I; Papakonstanti EA; Stathopoulos EN; Hatzoglou A; Stournaras C; Gravanis A; Castanas E
Mol Cancer Ther; 2006 May; 5(5):1342-51. PubMed ID: 16731768
[TBL] [Abstract][Full Text] [Related]
6. DJ-1 and androgen receptor immunohistochemical expression in prostatic carcinoma: a possible role in carcinogenesis.
Osman WM; Abd El Atti RM; Abou Gabal HH
J Egypt Natl Canc Inst; 2013 Dec; 25(4):223-30. PubMed ID: 24207095
[TBL] [Abstract][Full Text] [Related]
7. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis.
Kampa M; Nifli AP; Charalampopoulos I; Alexaki VI; Theodoropoulos PA; Stathopoulos EN; Gravanis A; Castanas E
Exp Cell Res; 2005 Jul; 307(1):41-51. PubMed ID: 15922725
[TBL] [Abstract][Full Text] [Related]
8. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
Abd El-Maqsoud NM; Osman NA; Abd El-Hamid AM; Fath El-Bab TK; Galal EM
Clin Genitourin Cancer; 2016 Apr; 14(2):e143-52. PubMed ID: 26794392
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
Hong H; Kao C; Jeng MH; Eble JN; Koch MO; Gardner TA; Zhang S; Li L; Pan CX; Hu Z; MacLennan GT; Cheng L
Cancer; 2004 Jul; 101(1):83-9. PubMed ID: 15221992
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
11. Novel oligomeric proanthocyanidin derivatives interact with membrane androgen sites and induce regression of hormone-independent prostate cancer.
Kampa M; Theodoropoulou K; Mavromati F; Pelekanou V; Notas G; Lagoudaki ED; Nifli AP; Morel-Salmi C; Stathopoulos EN; Vercauteren J; Castanas E
J Pharmacol Exp Ther; 2011 Apr; 337(1):24-32. PubMed ID: 21205921
[TBL] [Abstract][Full Text] [Related]
12. TRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells.
Asuthkar S; Velpula KK; Elustondo PA; Demirkhanyan L; Zakharian E
Oncotarget; 2015 Jul; 6(19):17221-36. PubMed ID: 25980497
[TBL] [Abstract][Full Text] [Related]
13. Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells.
Stathopoulos EN; Dambaki C; Kampa M; Theodoropoulos PA; Anezinis P; Delakas D; Delides GS; Castanas E
BMC Clin Pathol; 2003 Jan; 3():1. PubMed ID: 12588669
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of High Androgen Receptor Expression in Prostatic Acinar Adenocarcinoma.
Hashmi AA; Mudassir G; Irfan M; Hussain ZF; Hashmi SK; Asif H; Nisar L; Naeem M; Faridi N
Asian Pac J Cancer Prev; 2019 Mar; 20(3):893-896. PubMed ID: 30912411
[TBL] [Abstract][Full Text] [Related]
15. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
Montgomery BT; Young CY; Bilhartz DL; Andrews PE; Prescott JL; Thompson NF; Tindall DJ
Prostate; 1992; 21(1):63-73. PubMed ID: 1379363
[TBL] [Abstract][Full Text] [Related]
16. Membrane androgen receptor characteristics of human ZIP9 (SLC39A) zinc transporter in prostate cancer cells: Androgen-specific activation and involvement of an inhibitory G protein in zinc and MAP kinase signaling.
Thomas P; Pang Y; Dong J
Mol Cell Endocrinol; 2017 May; 447():23-34. PubMed ID: 28219737
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
[TBL] [Abstract][Full Text] [Related]
18. Rapid membrane effect of testosterone in LNCaP cells.
Wang Z; Liu L; Hou J; Wen D; Yan C; Pu J; Ouyang J; Pan H
Urol Int; 2008; 81(3):353-9. PubMed ID: 18931557
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor expression and DNA content of paraffin-embedded archival human prostate tumors.
Adiga SK; Andritsch I; Rao RV; Krishan A
Cytometry; 2002 Feb; 50(1):25-30. PubMed ID: 11857595
[TBL] [Abstract][Full Text] [Related]
20. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo.
Hatzoglou A; Kampa M; Kogia C; Charalampopoulos I; Theodoropoulos PA; Anezinis P; Dambaki C; Papakonstanti EA; Stathopoulos EN; Stournaras C; Gravanis A; Castanas E
J Clin Endocrinol Metab; 2005 Feb; 90(2):893-903. PubMed ID: 15585562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
